Synopsys/$SNPS
1D1W1MYTD1Y5YMAX
Capital at risk
About Synopsys
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
- Ticker
- $SNPS
- Sector
- Software & Cloud Services
- Primary listing
- NASDAQ
- Employees
- 28,000
- Headquarters
- Sunnyvale, United States
- Website
- www.synopsys.com
Synopsys Metrics
BasicAdvanced
$74B
68.26
$5.64
1.23
-
Price and volume
Market cap
$74B
Beta
1.23
52-week high
$539.48
52-week low
$362.55
Average daily volume
1.8M
Financial strength
Current ratio
1.337
Quick ratio
1.166
Long term debt to equity
0.311
Total debt to equity
0.348
Interest coverage (TTM)
1.66%
Profitability
EBITDA (TTM)
2,075.486
Gross margin (TTM)
82.92%
Net profit margin (TTM)
11.43%
Operating margin (TTM)
11.03%
Effective tax rate (TTM)
17.17%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
1.35%
Return on equity (TTM)
3.66%
Valuation
Price to earnings (TTM)
68.26
Price to revenue (TTM)
7.755
Price to book
2.37
Price to tangible book (TTM)
-10.33
Price to free cash flow (TTM)
26.576
Free cash flow yield (TTM)
3.76%
Free cash flow per share (TTM)
14.485
Growth
Revenue change (TTM)
46.33%
Earnings per share change (TTM)
-55.49%
3-year revenue growth (CAGR)
22.40%
10-year revenue growth (CAGR)
14.76%
3-year earnings per share growth (CAGR)
-5.35%
10-year earnings per share growth (CAGR)
13.66%
What the Analysts think about Synopsys
Analyst ratings (Buy, Hold, Sell) for Synopsys stock.
Analyst projections of the future price of Synopsys stock.
Bulls say / Bears say
Synopsys beat estimates in Q2 with revenue of $2.276 billion versus an IBES consensus of $2.251 billion and adjusted net income of $643.7 million topping forecasts of $607.2 million, reflecting robust demand for its tools. (Reuters)
On May 27, Synopsys raised its fiscal 2026 revenue outlook to $9.63 billion–$9.71 billion from $9.56 billion–$9.66 billion, with a midpoint above analyst consensus, signaling confidence in sustained AI-driven growth. (Reuters)
Following its $35 billion Ansys acquisition, Synopsys rolled out the Ansys 2026 R1 release—its first suite of AI-powered joint EDA and simulation tools—positioning the company to capture expanding AI chip-design workflows. (Reuters)
Synopsys warned that export restrictions in China led to a slight year-over-year decline in revenue excluding the Ansys unit, underscoring geopolitical headwinds in a key market. (Reuters)
Analysts project Synopsys’ net income to fall about 51% in fiscal 2026 to roughly $648 million, as integration expenses and amortization from the $35 billion Ansys acquisition weigh on earnings. (S&P Global)
Capacity shifts toward AI chips are squeezing production of consumer device semiconductors, hurting Synopsys’ IP segment licensing revenue and highlighting concentration risk in legacy markets. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 27 Aug 2026.
Synopsys Financial Performance
Revenues and expenses
Synopsys Earnings Performance
Company profitability
Upcoming events
No upcoming events
Synopsys News
AllArticlesVideos
Funds containing Synopsys
AllEURGBPUSD
Fund name | Fund size | $SNPS weighting |
|---|---|---|
VanEck Quantum Computing€QUTM | €199M | 3.51% |
Vaneck Quantum Computing£QNTG | £172M | 3.51% |
WisdomTree Artificial Intelligence€WTAI | €996M | 1.89% |
WisdomTree Artificial Intelligence£INTL | £870M | 1.89% |
Wisdomtree Quantum Computing€WQTM | €336M | 1.38% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.